Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate.

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)
Original languageEnglish
Pages (from-to)2651-2660
Number of pages10
JournalVaccine
Volume21(19-20)
Issue number19-20
Publication statusPublished - 02 Jun 2003

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this